Candida Albicans: a molecular revolution built on lessons from budding yeast
Related Experiment Video
Updated: Sep 28, 2026

CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans
Published on: November 14, 2018
Judith Berman1, Peter E Sudbery
1Department of Genetics, Cell Biology and Development, 6-160 Jackson Hall, 321 Church Street SE, Minneapolis, Minnesota 55455, USA. judith@cbs.umn.edu
Abstract:
Candida albicans is an opportunistic fungal pathogen that is found in the normal gastrointestinal flora of most healthy humans. However, in immunocompromised patients, blood-stream infections often cause death, despite the use of anti-fungal therapies. The recent completion of the C. albicans genome sequence, the availability of whole-genome microarrays and the development of tools for rapid molecular-genetic manipulations of the C. albicans genome are generating an explosion of information about the intriguing biology of this pathogen and about its mechanisms of virulence. They also reveal the extent of similarities and differences between C. albicans and its benign relative, Saccharomyces cerevisiae.
More Related Videos
Related Concept Videos
Candidiasis
Yeast Signaling
Modern Molecular Taxonomy
Applications of Molecular Taxonomy
Fungal Phylum Ascomycota
Bioreactor Controls-III

